A scientist using a pipette.

A Leader in Scientific Breakthroughs

BrightFocus Foundation is a premier private funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma.  We are currently managing a nearly $75+ million global portfolio of more than 280 scientific projects.

Recently Funded

Learn more about grants awarded in the most current fiscal year (nearly $25 million in funding for 95new awards in FY2022).

Culture of cortical neurons.

Nearly $14 million in funding for 55 new ADR awards in FY22.

A senior man having an eye exam.

Nearly $7 million in funding for 21 new MDR awards in FY22.

A close up of an eye.

Nearly $4 million in funding for 19 new NGR awards in FY22.

Latest News

Research News

Clinical trial results released Nov. 29 for lecanemab, a drug targeting early Alzheimer’s disease, reported a moderate slowing of cognitive decline in patients by 25% through the removal of amyloid-beta (Aβ) in the brain.

Nov 30, 2022
Research News

A new oral pill for geographic atrophy is being tested in an early-stage clinical trial.

Aug 12, 2022
Research News

Gael Chetelat, PhD, University of Caen-Normandy, France, was honored on Oct. 21, 2022, by Women’s Health Access Matters for her BrightFocus-funded project, “Sex Differences in Risk Profiles Across the Alzheimer’s Disease Continuum.”

Nov 15, 2022